Press Room

News / Jun 23, 2023

2023 International Women Engineering Day

Make Safe Seen

International Women in Engineering Day_Hovione

This year’s theme for International Women in Engineering Day is #makesafetyseen to celebrate the achievements of women around the world in engineering.

Hear from some of our engineers as they share their career journeys and empower others to break barriers in the healthcare field.

Thank you to Ana Rafael (Principal HSE Specialist) Catarina Coelho (Senior QC Technical Specialist), and Luísa Paulo (Corporate Quality Senior Director I) for making safety seen.

 Read their statements here.

2023 International Women Engineering Day_Ana Rafael | Hovione
 

“I would like to say a word to empower young girls and show them the incredible potential of women in engineering. Engineering is not just about math and science — it's about designing safer, environmentally friendly systems, collaborating, and embracing entrepreneurship. As women in engineering, we are making a profound impact on society.

I proudly graduated in Chemical Engineering from the University of Coimbra, where both boys and girls were determined to leave their mark on the world. I began my career as a researcher, simulating distillation processes. However, my passion for the environment led me to shift my focus towards engineering design for biofuels and environmental treatment plants. It was then that everything fell into place — I knew I wanted to create a better world.

Years later, I seized the opportunity to start my own business, dedicated to enhancing the environmental efficiency and sustainability of various industries across Europe, KSA, and Angola. This journey taught me the importance of sustainable practices and the dedication required to secure our place in the future.

Today, at Hovione, I’m able to balance both of my passions: contributing to life-saving medicines and ensuring that all of us do our jobs in a safely manner. For ourselves and for the communities where we are in. For the past 8 years, I have led and managed teams and projects, guiding Hovione sites towards a better, safer and more sustainable future. I never stop learning and embracing challenges.

I believe in the power of women, driving positive change and breaking barriers. Together, we can create a safer world where women in engineering thrive and shape a brighter future for all."

Ana Rafael - Principal HSE Specialist

Hovione Portugal 

2023 International Women Engineering Day_Catarina Coelho | Hovione
 

"On International Women in Engineering Day, I take this time to reflect on my journey as a woman in the engineering field.

One of the most rewarding experiences in my journey was the opportunity to work as Senior Analytical Chemist at Hovione. In this role, I had the privilege of contributing to the design and implementation of innovative solutions.

On this special day, let us celebrate the remarkable achievements of women engineers worldwide. Together, we are transforming the landscape of engineering, breaking down barriers and forging a path for future generations of aspiring engineers."

Catarina Coelho - Senior QC Technical Specialist

Hovione Portugal

2023 International Women Engineering Day_ Luísa Paulo | Hovione
 

"I have been working as a Chemical Engineer for 40 years and I would like to motivate the young women who love engineering to pursue their dream. At Hovione, I have always felt appreciated and encouraged by my colleagues."

Luísa Paulo - Corporate Quality Senior Director I

Hovione New Jersey

Also in the Press Room

See All

The CDMO’s New Jersey manufacturing site expansion will eventually cover more than 200,000 square feet. Portugal-based contract development and manufacturing organisation (CDMO) Hovione has completed an initial $100 million investment round in its East Windsor, New Jersey site. Once completed it will increase the facility’s footprint to more than 200,000 square feet and more than double its capacity for spray drying. Hovione CEO Jean-Luc Herbeaux said: “Since launching our New Jersey operations in 2002, Hovione has been one of the longest established European CDMOs in the United States. “This investment reinforces Hovione’s leadership in spray drying – a core technology platform where we have built extensive know-how and capabilities. By continuing to advance our platforms and expand capacity in the US, we are strengthening the foundation that enables our partners to bring complex medicines to patients more efficiently.” Spray drying is an increasingly important particle engineering technology for improving drug bioavailability through the amorphous solid dispersion (ASD) that can address bioavailability or crystallisation challenges. The initial phase of Hovione’s expansion will include a 31,000-square-foot building to house two size-3 spray dryers (PSD-3) designed for ASD production. Construction at the New Jersey site is already underway and the company plans to start GMP operations in the second quarter of 2026. The initiative is part of Hovione’s long-term strategy to grow its US operations and enhance its integrated drug substance, drug product intermediate and drug product capabilities. Herbeaux said: “This investment addresses growing customer demand for US-based capacity and integrated solutions that shorten development timelines and reduce tech transfer complexity. By consolidating development, scale-up, and commercial manufacturing within a single quality and governance framework, we provide customers with seamless execution from drug substance to drug product.” The company’s New Jersey expansion fits into its wider international growth plan that also includes capacity investments in Ireland and Portugal as it seeks to create a network of autonomous sites spanning the development and commercialisation of APIs, drug product intermediates and drug products.   Read the full article at EuropeanPharmaceuticalReview.com  

Press Clipping

Hovione doubles spray drying capacity with $100m US investment round

Nov 04, 2025

The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scientific, Lonza, SK pharmteco/Lotte Biologics, Hovione, Sai Life Sciences, BioCina, Alcami, Piramal Pharma/IntoCell and Roquette. Formulation Development/Drug Product Manufacturing: Hovione Completes Initial $100-M Investment Cycle in US Operations Hovione, a CDMO of drug substances and drug products, has completed an initial $100-million investment cycle at its site in East Windsor, New Jersey, as part of a strategy to increase its US operations and enhance its integrated drug-substance, drug-product intermediate, and drug-product capabilities. Upon completion, the site will cover more than 200,000 square feet.   The initial expansion phase includes a 31,000-square-foot building that will house two size-3 spray dryers (PSD-3) designed for production of amorphous solid dispersions (ASDs). This investment more than doubles Hovione’s spray-drying capacity in the US by expanding capabilities for ASD development and commercial manufacturing. Construction is underway at the New Jersey site, with GMP operations planned to start in the second quarter of 2026.  As part of this expansion, Hovione has also acquired additional adjacent land to enable future growth at the East Windsor site. The 125,000-square-foot greenfield will support large-scale production, including continuous and batch tableting capacity, and introduce the latest pharmaceutical technologies and digital innovation with enhanced quality control and R&D capabilities.    Read the full article at DCATvci.org  

Press Clipping

Supplier News: Thermo Fisher, Lonza, SK pharmteco, Hovione & More

Oct 30, 2025

Today marks the start of CPhI Frankfurt, a huge trade show in Germany focused on the supply of pharmaceutical ingredients and other services to the drug industry. C&EN editor in chief Nick Perkins, life sciences editor Laura Howes, and reporter Aayushi Pratap are all there to meet drug outsourcing executives and take the pulse of the sector. In advance of CPhI, Cambrex and Wilmington PharmaTech both just announced big investments in US plants that make active pharmaceutical ingredients. And the Portuguese pharmaceutical services firm Hovione says it has completed a $100 million investment in New Jersey (story below). (...) Hovione invests in spray-drying in New Jersey The pharmaceutical services firm Hovione says it has spent $100 million to expand its operation in East Windsor, New Jersey. The facility spray-dries drug ingredients to create amorphous solid dispersions, which improve solubility and bioavailability. The Portuguese company says the new spray dryers will begin operating in the second quarter of 2026. The New Jersey facility opened in 2002, making Hovione one of the longest-established European pharmaceutical services firms in the US, CEO Jean-Luc Herbeaux says in a press release. Hovione says it has purchased land adjacent to the East Windsor site on which it can add new facilities for services such as spray-drying and drug tableting. Hovione is also investing at its sites in Ireland and Portugal. —Michael McCoy   Read the full article at CEN.acs.org  

Press Clipping

Oct. 28 Business Watch: More plants closing in Europe, Novartis to pay $12 billion for biotech firm

Oct 28, 2025